type here...

CATEGORIES

Cancers

LATEST

1234...19Page 3 of 19

TRENDING

EDITORS CHOICE

Researchers Control Cancer Treatment With New Innovation: CAR T Switch(Blade)

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Liver Cancer, HCC (Hepatocellular Carcinoma)

Medika Life -
Liver cancer includes hepatocellular carcinoma (HCC) and bile duct cancer (cholangiocarcinoma). Risk factors for HCC include chronic infection with hepatitis B or C and cirrhosis of the liver.

Why Fossil Fuel Industry Efforts Must be Monitored Before and During COP28

Gil Bashe, Medika Life Editor -
Why the UAE May be the Right Venue for the World’s Most Important Climate Change Gathering?

CAR T Therapy For Drug Resistant Multiple Myeloma

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.”

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories